In corporate news, Novo Nordisk A/S (NOVOB.C.DX) surged over +7% after the pharmaceutical giant reported better-than-expected Q3 sales of its popular Wegovy weight-loss drug and narrowed its full-year ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

While AstraZeneca and Novo Nordisk are developing similar candidates ... diluted by new issuance like buying many other biotech stocks would. At the end of Q3, it had more than $930 million in cash, ...

According to a March 2023 study from the Bank of America Institute about consumer spending, seniors born in 1964 or earlier ...

Canadian drugmaker Apotex hired banks to prepare for its IPO. Novo Nordisk reported its net profit in Q3 hit 27.3 billion Danish kroner, just above an aggregate estimate of 26.95 billion Danish kroner ...

Evotec Ag (Adr) ( (EVO) ) has released its Q3 earnings. Here is a breakdown of the information Evotec Ag (Adr) presented to its investors.

Novo Nordisk ( (NVO) ) has released its Q3 earnings. Here is a breakdown of the information Novo Nordisk presented to its investors. Novo ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.

"This is a forward-looking statement, mathematically based, and we'll come back with the more detailed guidance come early February 2025," Knudsen said. He said that absolute sales growth last year ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Welcome to the third-quarter 2024 Novo Nordisk A/S earnings conference call. [Operator instructions] Please be advised that ...